Radiologist Henry C. Lusane, MD, with Acumen Medical Imaging, interpreted the scans, reporting the mass as benign, a mistake later leading to a terminal cancer diagnosis.
The Women’s Center for Radiology, which was acquired by Solis Mammography in January, hired a cybersecurity firm to help investigate the scope of the matter.
Most medical societies urge their clinical-guidance developers to include cost data alongside care recommendations. Yet less than a quarter of published advisements—22.5%—contain evidence-based discussions on economic considerations or resource consumption.
The health network, which operates 37 hospitals in California, drastically reduced scheduling delays after integrating an FDA-cleared algorithm designed to speed up imaging acquisition times.
A report from Trilliant Health looking at payer data found that, as prescriptions for the popular weight loss drugs spike, so rises the number of approved benefits.
Fears about the risk of sudden cardiac arrest are being used to order unnecessary electrocardiogram and echocardiograms for young athletes, according to a new warning from multiple federal agencies.
Ahead of June 1 to 5—Medicare Fraud Prevention Week—here’s a timeline of fraud-related news, views and developments as captured in concise statements uttered or written in May.
Details are slim, but Ōura Health confirmed it submitted a draft registration with the Securities and Exchange Commission. The company received $900 million in new funding from investors in October.
The same day that Tennessee Gov. Bill Lee signed a bill that would force pharmacy benefit managers to divest from retail pharmacies, CVS Health filed a lawsuit to block its implementation.
Radiologist Henry C. Lusane, MD, with Acumen Medical Imaging, interpreted the scans, reporting the mass as benign, a mistake later leading to a terminal cancer diagnosis.
The Women’s Center for Radiology, which was acquired by Solis Mammography in January, hired a cybersecurity firm to help investigate the scope of the matter.
Most medical societies urge their clinical-guidance developers to include cost data alongside care recommendations. Yet less than a quarter of published advisements—22.5%—contain evidence-based discussions on economic considerations or resource consumption.
